Unbound Prime | Dig Liver Dis

(Dig Liver Dis[TA])

6,847 results

Author's reply: "Frailty in IBD: The missing axis in treat-to-target decision-making". [Letter]
Dig Liver Dis. 2026 Sep 07. [Online ahead of print]Marafini I, Salvatori S, Monteleone GDL
Publisher Full Text (DOI)

Steatosis liver index: A validated machine learning model using clinical data distinguishes steatotic liver disease phenotypes. [Journal Article]
Dig Liver Dis. 2026 Sep 05. [Online ahead of print]Pagadala M, Khurshid T, … Singal AKDL
CONCLUSIONS: This novel SLI may provide a clinical tool for both practice and research settings to stratify SLD phenotypes.
Publisher Full Text (DOI)

Gastric heterotopic salivary gland tissue. [Editorial]
Dig Liver Dis. 2026 Sep 05. [Online ahead of print]Lang BJ, Lin XY, Liu WDL
Publisher Full Text (DOI)

Rectal bleeding in early infancy: a warning sign of necrotizing enterocolitis that should not be overlooked in high-risk infants. [Journal Article]
Dig Liver Dis. 2026 Sep 05. [Online ahead of print]De Rose DU, Pugnaloni F, … Di Pede ADL
CONCLUSIONS: NEC is the leading cause of rectal bleeding in early infancy, followed by IRB. Although IRB is often benign, rectal bleeding should always prompt careful evaluation, particularly in high-risk infants such as those with CHD and those born preterm, in whom rectal bleeding may represent an early manifestation of NEC. Early recognition and close monitoring are essential to optimize outcomes.
Publisher Full Text (DOI)

Comparative performance of HCC risk scores in identifying low-risk patients with cirrhosis: A multicenter cohort study. [Journal Article]
Dig Liver Dis. 2026 Sep 02. [Online ahead of print]Moussa M, de Wit K, … Sonneveld MJDL
CONCLUSIONS: THRI appears more effective than aMAP in identifying patients with negligible 5-year HCC risk and may inform personalized HCC surveillance strategies, particularly in supporting deferral decisions in low-risk patients.
Publisher Full Text (DOI)

Beyond MASLD: cardiometabolic dysfunction across liver disease etiologies. [Editorial]
Dig Liver Dis. 2026 Aug 31. [Online ahead of print]Cinque F, Fracanzani ALDL
Publisher Full Text (DOI)

Liver transplant allocation by milan criteria may exclude eligible HCC patients without survival benefit - a post-hoc analysis of the SiLVER study. [Journal Article]
Dig Liver Dis. 2026 Aug 30. [Online ahead of print]Kupke P, Schmitt KC, … International SiLVER study groupDL
CONCLUSIONS: Our data based on explant histopathology suggest that Milan criteria exclude patients with HCC evaluated for LTx without demonstrable benefit, questioning Milan criteria as sole selection tool in many regions doing liver transplants.
Publisher Full Text (DOI)

Ivonescimab in combination with chemotherapy in advanced or metastatic gastric cancer (GC) or esophagogastric junction cancer (EGJC): The UCGI 52 - GRACIE trial. [Journal Article]
Dig Liver Dis. 2026 Aug 30. [Online ahead of print]Raimbourg J, Botsen D, … de la Fouchardière CDL
CONCLUSIONS: GRACIE will provide crucial information about Ivonescimab plus chemotherapy regimens efficacy either as a first- or second-line treatment in molecularly defined advanced/metastatic gastric and esophageal adenocarcinomas to inform future phase III trials.
Publisher Full Text (DOI)

Ascites resulting from combined hepatic arterioportal and arteriovenous fistulas. [Editorial]
Dig Liver Dis. 2026 Aug 30. [Online ahead of print]Tang SS, Tao Y, … Liu WDL
Publisher Full Text (DOI)

Different trends in intestinal and perianal surgery rates in patients with Crohn's disease in Austria: A nationwide population-based study. [Journal Article]
Dig Liver Dis. 2026 Aug 27. [Online ahead of print]Wisniowski K, Ritschl V, … Austrian IBD Study Group (ATISG)DL
CONCLUSIONS: In Austrian CD patients intestinal resection rates remained stable, whereas perianal fistula surgeries increased. Adjustment for rising CD prevalence revealed fewer intestinal resections per CD patient years, while perianal fistula surgery rates continued to increase.
Publisher Full Text (DOI)

Frailty in IBD: The missing axis in treat-to-target decision-making. [Letter]
Dig Liver Dis. 2026 Aug 26. [Online ahead of print]Xie A, Chen XDL
Publisher Full Text (DOI)

Log in to Prime